###begin article-title 0
###xml 0 4 0 4 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Erk1</italic>
###xml 9 13 9 13 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Erk2</italic>
###xml 75 80 <span type="species:ncbi:10090">Mouse</span>
Erk1 and Erk2 Regulate Endothelial Cell Proliferation and Migration during Mouse Embryonic Angiogenesis
###end article-title 0
###begin p 1
Conceived and designed the experiments: MO. Performed the experiments: RS TZ HH. Analyzed the data: RS TZ HH JZ PG SF GL MO. Contributed reagents/materials/analysis tools: CJK GL MO. Wrote the paper: RS GL GL MO. Provided critical input to the manuscript:.
###end p 1
###begin p 2
###xml 312 320 312 320 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 418 425 418 425 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 450 458 450 458 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cre/loxP</italic>
###xml 493 497 493 497 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Erk1</italic>
###xml 502 506 502 506 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Erk2</italic>
###xml 638 642 638 642 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Erk1</italic>
###xml 647 651 647 651 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Erk2</italic>
###xml 1058 1062 1058 1062 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Erk1</italic>
###xml 1067 1071 1067 1071 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Erk2</italic>
###xml 1077 1084 1077 1084 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 1089 1097 1089 1097 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 535 541 <span type="species:ncbi:10090">murine</span>
Angiogenesis is a complex process orchestrated by both growth factors and cell adhesion and is initiated by focal degradation of the vascular basement membrane with subsequent migration and proliferation of endothelial cells. The Ras/Raf/MEK/ERK pathway is required for EC function during angiogenesis. Although in vitro studies implicate ERK1 and ERK2 in endothelial cell survival, their precise role in angiogenesis in vivo remains poorly defined. Cre/loxP technology was used to inactivate Erk1 and Erk2 in endothelial cells during murine development, resulting in embryonic lethality due to severely reduced angiogenesis. Deletion of Erk1 and Erk2 in primary endothelial cells resulted in decreased cell proliferation and migration, but not in increased apoptosis. Expression of key cell cycle regulators was diminished in the double knockout cells, and decreased DNA synthesis could be observed in endothelial cells during embryogenesis. Interestingly, both Paxillin and Focal Adhesion Kinase were expressed at lower levels in endothelial cells lacking Erk1 and Erk2 both in vivo and in vitro, leading to defects in the organization of the cytoskeleton and in cell motility. The regulation of Paxillin and Focal Adhesion Kinase expression occurred post-transcriptionally. These results demonstrate that ERK1 and ERK2 coordinate endothelial cell proliferation and migration during angiogenesis.
###end p 2
###begin title 3
Introduction
###end title 3
###begin p 4
###xml 143 146 143 146 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008283-Jain1">[1]</xref>
###xml 592 595 592 595 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008283-Cheresh1">[2]</xref>
Angiogenesis is a multi-step process involving a concerted remodeling of the primitive vascular plexus to a mature functional vascular network [1]. It is a fundamental process in normal growth and development. It is also an essential element in processes such as wound healing and inflammation, and in many pathological conditions, such as cancer. Soluble factors including vascular endothelial growth factor (VEGF) play key roles in this initial process, but cell adhesion/extracellular matrix interactions are also critical determinants of endothelial cell (EC) migration and proliferation [2].
###end p 4
###begin p 5
###xml 162 165 162 165 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008283-Eliceiri1">[3]</xref>
###xml 167 170 167 170 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008283-Hood1">[4]</xref>
###xml 172 175 172 175 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008283-Liu1">[5]</xref>
###xml 177 180 177 180 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008283-Pintucci1">[6]</xref>
###xml 182 185 182 185 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008283-Serban1">[7]</xref>
###xml 247 252 247 252 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B-Raf</italic>
###xml 254 258 254 258 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MEK1</italic>
###xml 263 270 263 270 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ras-GAP</italic>
###xml 319 322 319 322 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008283-GalabovaKovacs1">[8]</xref>
###xml 324 327 324 327 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008283-Giroux1">[9]</xref>
###xml 329 333 329 333 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008283-Henkemeyer1">[10]</xref>
###xml 335 339 335 339 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008283-Wojnowski1">[11]</xref>
###xml 354 357 354 357 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 350 357 350 357 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Erk1<sup>&#8722;/&#8722;</sup></italic>
###xml 404 408 404 408 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008283-Selcher1">[12]</xref>
###xml 410 414 410 414 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008283-Pages1">[13]</xref>
###xml 423 426 423 426 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 419 426 419 426 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Erk2<sup>&#8722;/&#8722;</sup></italic>
###xml 499 503 499 503 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008283-Yao1">[14]</xref>
###xml 505 509 505 509 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008283-Hatano1">[15]</xref>
###xml 511 515 511 515 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008283-SabaElLeil1">[16]</xref>
###xml 850 854 850 854 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008283-Alavi1">[17]</xref>
###xml 856 860 856 860 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008283-Hood2">[18]</xref>
###xml 862 866 862 866 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008283-Klemke1">[19]</xref>
###xml 868 872 868 872 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008283-Mavria1">[20]</xref>
###xml 874 878 874 878 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008283-Murphy1">[21]</xref>
###xml 880 884 880 884 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008283-Son1">[22]</xref>
###xml 892 900 892 900 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 993 997 993 997 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008283-Alavi1">[17]</xref>
###xml 999 1003 999 1003 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008283-Hood2">[18]</xref>
###xml 1005 1009 1005 1009 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008283-Klemke1">[19]</xref>
###xml 1011 1015 1011 1015 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008283-Mavria1">[20]</xref>
###xml 1017 1021 1017 1021 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008283-Murphy1">[21]</xref>
###xml 1023 1027 1023 1027 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008283-Son1">[22]</xref>
###xml 1272 1276 1272 1276 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008283-Avraham1">[23]</xref>
###xml 1278 1282 1278 1282 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008283-Gupta1">[24]</xref>
###xml 1284 1288 1284 1288 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008283-Parenti1">[25]</xref>
###xml 1290 1294 1290 1294 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008283-Pedram1">[26]</xref>
###xml 1296 1300 1296 1300 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008283-Rousseau1">[27]</xref>
###xml 1302 1306 1302 1306 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008283-Rousseau2">[28]</xref>
###xml 1308 1312 1308 1312 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008283-Wallez1">[29]</xref>
###xml 1314 1318 1314 1318 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008283-Yu1">[30]</xref>
###xml 358 362 <span type="species:ncbi:10090">mice</span>
###xml 427 431 <span type="species:ncbi:10090">mice</span>
Of the array of signaling events activated in response to VEGF and cell adhesion, the Ras/Raf/MEK/ERK1/2 pathway is known to play a prominent role in EC function [3], [4], [5], [6], [7]. Targeted deletion of genes in the Ras pathway, for example, B-Raf, MEK1 and Ras-GAP, leads to vascular defects during embryogenesis [8], [9], [10], [11]. However, Erk1-/- mice are viable with no angiogenic phenotypes [12], [13] and Erk2-/- mice are embryonic lethal before vascularization and angiogenesis occur [14], [15], [16]. A large body of work demonstrates that the mitogen activated protein kinases ERK1 and ERK2 (ERK1/2) are critical for angiogenesis: however, the data is largely based on cell culture studies using dominant negative genes, siRNA and small molecule inhibitors to antagonize the kinases that lie upstream of ERK in the signaling pathway [17], [18], [19], [20], [21], [22]. These in vitro studies implicate the Ras/Raf pathway, and by extension ERK1/2, in EC survival and motility [17], [18], [19], [20], [21], [22]. However, besides Erk, many other signaling cascades such as src, FAK, PI3K/Akt, p38MAPK and JNK function downstream of growth factor and cell adhesion receptors, and many of these pathways have been implicated in the same biological processes [23], [24], [25], [26], [27], [28], [29], [30].
###end p 5
###begin p 6
###xml 104 112 104 112 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cre/loxP</italic>
###xml 148 152 148 152 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Erk2</italic>
###xml 156 160 156 160 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Erk1</italic>
###xml 193 201 193 201 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tie2-Cre</italic>
###xml 201 205 201 205 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008283-Kisanuki1">[31]</xref>
###xml 223 229 223 229 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Erk1/2</italic>
###xml 241 249 241 249 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in utero</italic>
###xml 601 608 601 608 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 613 621 613 621 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 986 990 986 990 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Erk1</italic>
###xml 995 999 995 999 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Erk2</italic>
###xml 166 170 <span type="species:ncbi:10090">mice</span>
In order to better understand how ERK1 and ERK2 regulate angiogenesis, we used a genetic approach using Cre/loxP technology to conditionally delete Erk2 in Erk1-null mice using the EC specific Tie2-Cre[31]. Embryos lacking Erk1/2 in EC died in utero at E10.5 due to reduced angiogenesis both in the yolk sac and embryo proper. Gene expression profiling of isolated aortic EC identified cell cycle and cell migration as the principal biological processes affected in the double mutant EC. Consistent with the microarray profiling, EC lacking ERK1/2 show highly reduced proliferation and migration both in vivo and in vitro. The mechanism by which ERK1/2 regulated cell proliferation involved transcriptional regulation of genes necessary for cell cycle, including CyclinA, CyclinB, CyclinD1, CyclinE and c-Myc. Additionally ERK1/2 regulated the abundance of proteins like Paxillin and Focal Adhesion Kinase that are required for cell migration. These results reveal a redundant role for Erk1 and Erk2 in coordinating EC proliferation and migration, two processes necessary for embryonic angiogenesis.
###end p 6
###begin title 7
Materials and Methods
###end title 7
###begin title 8
###xml 0 4 <span type="species:ncbi:10090">Mice</span>
Mice
###end title 8
###begin p 9
###xml 0 9 0 9 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Erk1-null</italic>
###xml 18 20 18 20 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fl</sup>
###xml 14 20 14 20 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Erk2<sup>fl</sup></italic>
###xml 52 56 52 56 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008283-Selcher1">[12]</xref>
###xml 58 62 58 62 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008283-Samuels1">[32]</xref>
###xml 72 74 72 74 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fl</sup>
###xml 68 74 68 74 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Erk2<sup>fl</sup></italic>
###xml 87 91 87 91 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">loxP</italic>
###xml 188 197 188 197 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Erk2-null</italic>
###xml 201 208 201 208 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Erk2-KO</italic>
###xml 217 225 217 225 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tie2-Cre</italic>
###xml 257 261 257 261 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008283-Kisanuki1">[31]</xref>
###xml 21 25 <span type="species:ncbi:10090">mice</span>
###xml 75 79 <span type="species:ncbi:10090">mice</span>
###xml 226 230 <span type="species:ncbi:10090">mice</span>
###xml 335 339 <span type="species:ncbi:10090">Mice</span>
###xml 435 439 <span type="species:ncbi:10090">mice</span>
Erk1-null and Erk2fl mice were described previously [12], [32]. The Erk2fl mice harbor loxP sites flanking exon 2. Cre-mediated recombination of this site results in the generation of the Erk2-null or Erk2-KO allele. Tie2-Cre mice were described previously [31]. All animals were maintained on pure C57/BL6 background (5 generations). Mice were genotyped by PCR. Primers and conditions used are available upon request. Use and care of mice in this study were approved by the Ohio State University Institutional Animal Care and Use Committee.
###end p 9
###begin title 10
Isolation of endothelial cells
###end title 10
###begin p 11
###xml 48 51 48 51 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 58 61 58 61 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">/fl</sup>
###xml 44 61 44 61 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Erk1<sup>&#8722;/&#8722;</sup>;Erk2fl<sup>/fl</sup></italic>
###xml 70 73 70 73 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 78 82 78 82 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fl/f</sup>
###xml 66 82 66 82 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Erk1<sup>+/&#8722;</sup>;Erk2<sup>fl/f</sup></italic>
###xml 112 116 112 116 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008283-Huang1">[33]</xref>
###xml 118 122 118 122 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008283-Rose1">[34]</xref>
###xml 662 663 648 649 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 0 5 <span type="species:ncbi:10090">Mouse</span>
###xml 83 87 <span type="species:ncbi:10090">mice</span>
Mouse aortic and lung EC were isolated from Erk1-/-;Erk2fl/fl and Erk1+/-;Erk2fl/f mice as previously described [33], [34]. Aortic and lung EC populations were labeled with 5 microg/mL Di-I-acetylated low-density lipoprotein (Di-I-Ac-LDL, Upstate) and enriched by fluorescent activated cell sorting as the final step of purification. The purified EC populations were characterized and maintained in complete EC medium (Dulbecco modifies Eagle medium (DMEM)-F12 with 20% heat inactivated FBS plus penicillin-streptomycin, 30 microg/ml endothelial cell growth supplement (Upstate Biotechnology) and 10 U/ml heparin (Sigma-Aldrich)) in 37degreesC incubator at 5% CO2.
###end p 11
###begin title 12
Lentiviral Transduction
###end title 12
###begin p 13
###xml 26 29 26 29 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 36 39 36 39 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">/fl</sup>
###xml 22 39 22 39 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Erk1<sup>&#8722;/&#8722;</sup>;Erk2fl<sup>/fl</sup></italic>
###xml 48 51 48 51 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 56 60 56 60 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fl/f</sup>
###xml 44 60 44 60 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Erk1<sup>+/&#8722;</sup>;Erk2<sup>fl/f</sup></italic>
###xml 69 70 69 70 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sup>
###xml 399 403 399 403 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008283-Wei1">[35]</xref>
Duplicate cultures of Erk1-/-;Erk2fl/fl and Erk1+/-;Erk2fl/f EC (5x105 cells) were cultured overnight and infected with ecotropic lentivirus with and without PGK-Cre, to generate control and double mutant (DKO) EC, respectively (pHAGE-IRES-GFP vectors used were a gift from Dr.N.Danial's laboratory at Harvard University). Infections of the duplicate cultures were performed as described previously [35]. The infected cells were harvested 72 hrs post-infection, when the endogenous pool of ERK2 present before infection was sufficiently depleted and morphological differences between control and DKO cells are first noted. All subsequent experiments were performed on the duplicate cultures, one infected with Cre and one without, beginning at 72 hrs post-infection.
###end p 13
###begin title 14
Quantitative real-time PCR
###end title 14
###begin p 15
###xml 200 204 200 204 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008283-Wei1">[35]</xref>
Total RNA was extracted from aortic and lung EC 72 hrs post viral infection by TRIzol (Invitrogen) according to the manufacturers' instructions. Samples were analyzed by q-PCR as previously described [35]. Students t-test was used to determine the statistical significance of the expression differences between the DKO and control genotypes.
###end p 15
###begin title 16
Microarray Analysis
###end title 16
###begin p 17
###xml 62 70 62 70 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0008283.s003">Table S3</xref>
###xml 189 193 189 193 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">eGFP</italic>
###xml 211 214 211 214 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cre</italic>
###xml 526 530 526 530 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008283-Irizarry1">[36]</xref>
###xml 357 362 <span type="species:ncbi:10090">Mouse</span>
A detailed description of microarray analysis is presented in Table S3. Briefly, cells used for this study were generated from three independent pairs of aortic EC infected with lentiviral-eGFP with and without Cre. RNA was extracted from control and DKO EC at 72 hrs post-lentivirus infection. Microarray was performed with these RNA samples on Affymetrix Mouse Exon v1.0 ST Array GPL6193 platform. RMA method was applied to the primary data to correct the technical bias and summarize gene expression values over probe-sets [36]. The gene expression differences were then compared between EC with or without ERK1/2. The gene list was filtered based on the fold change in expression between the two genotypes. Targets showing >4-fold significant (p<0.05) change in expression in the DKO compared to control EC were subjected to DAVID Annotation Analysis ().
###end p 17
###begin title 18
Histology and Immunostaining
###end title 18
###begin p 19
###xml 75 79 75 79 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008283-Suri1">[37]</xref>
###xml 255 259 251 255 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008283-Wei1">[35]</xref>
###xml 261 265 257 261 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008283-Braren1">[38]</xref>
###xml 296 299 <span type="species:ncbi:10116">rat</span>
###xml 336 342 <span type="species:ncbi:9986">rabbit</span>
###xml 369 375 <span type="species:ncbi:9986">rabbit</span>
###xml 417 422 <span type="species:ncbi:10090">mouse</span>
###xml 452 458 <span type="species:ncbi:9986">rabbit</span>
###xml 482 488 <span type="species:ncbi:9986">rabbit</span>
###xml 519 525 <span type="species:ncbi:9986">rabbit</span>
###xml 844 852 <span type="species:ncbi:405018">cardinal</span>
Whole-mount CD31 staining on embryos was performed as previously described [37]. Embryos were fixed in 4% paraformaldehyde (PFA) overnight, paraffin or OCT embedded and 5 microm sections were prepared. Immunostaining was performed as previously described [35], [38]. Primary antibodies used were rat anti- CD31 (MEC13.3, BD Phamingen), rabbit anti-ERK1/2 (Santa Cruz), rabbit anti-cleaved Caspase-3 (Cell Signaling), mouse anti-BrDU (DAKO Cytomation), rabbit anti-Paxillin (Abcam), rabbit anti-FAK (Cell Signaling) and rabbit anti-pY397-FAK (Abcam). Biotinylated secondary antibodies used were from BD Biosciences. The antibody staining was imaged using an Axioscope 40 microscope (Zeiss) equipped with an Axiocam HRc camera (Zeiss). Immunostaining was quantified in embryonic blood vessels in the head, lining the heart, the dorsal aorta, the cardinal vein, and the intersomatic vessels. At least 10 vessels (approximately400 EC) were counted per embryo in each group and were quantified using Metamorph 6.0. For non-EC, Metamorph 6.0 was used to count and quantify staining in all embryonic cell types (such as smooth muscle cells, epithelial cells, cardiomyocytes), especially cells adjacent to blood vessels. Approximately 1500 non-EC cells per embryo in each genetic group were counted and scored.
###end p 19
###begin p 20
###xml 368 369 364 365 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 368 369 364 365 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>&#8722;</sup></italic>
###xml 370 371 366 367 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</italic>
###xml 369 371 365 367 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">/<italic>&#8722;</italic></sup>
###xml 376 377 372 373 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 376 377 372 373 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>&#8722;</sup></italic>
###xml 378 379 374 375 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</italic>
###xml 377 379 373 375 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">/<italic>&#8722;</italic></sup>
###xml 128 134 <span type="species:ncbi:9793">donkey</span>
###xml 140 145 <span type="species:ncbi:10090">mouse</span>
EC plated on Fibronectin (FN)-coated dishes (10 microg/ml) were used for double immunofluorescence assays. Alexa-594 conjugated donkey anti-mouse (Invitrogen), Alexa-488/594 conjugated secondary antibodies (Invitrogen) were used for immunofluorescence analysis. Images of stained EC were acquired using a Zeiss 510 META laser scanning confocal microscope. For the Erk1-/-;Erk2-/- DKO cells, which express low levels of GFP through an IRES sequence, the FITC intensity of unstained DKO ECs was set as background. Using this as the basal level, FITC expression in Paxillin immunostained DKO EC was evaluated. Results presented have the GFP background signal filtered. To confirm the results, in separate single label experiments Paxillin was stained using the Alexa598 red conjugate (data not shown). Phalloidin labeling was performed on EC according to the manufacturers' instructions (Invitrogen). Immunostaining of EC in culture was performed 72 hrs post viral infection.
###end p 20
###begin title 21
Western Blotting
###end title 21
###begin p 22
###xml 150 154 150 154 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008283-Wei1">[35]</xref>
###xml 185 191 <span type="species:ncbi:9986">rabbit</span>
###xml 265 270 <span type="species:ncbi:10090">mouse</span>
###xml 363 369 <span type="species:ncbi:9986">rabbit</span>
###xml 393 399 <span type="species:ncbi:9986">rabbit</span>
###xml 414 420 <span type="species:ncbi:9986">rabbit</span>
###xml 451 457 <span type="species:ncbi:9986">rabbit</span>
Total protein was extracted from at least two control and DKO EC 72 hours post viral infection and western blot was performed as previously described [35]. Primary antibodies raised in rabbit against ERK1/2, CyclinD1, CyclinA, CyclinE, CyclinB1, CDK4 and CDK1, and mouse anti-c-Myc were purchased from Santa Cruz Biotechnology. Other primary antibodies used were rabbit anti-Paxillin (Abcam), rabbit pS473-AKT and rabbit anti-FAK (Cell Signaling) and rabbit anti-pY397-FAK (Abcam).
###end p 22
###begin title 23
Cell Proliferation and Migration assays
###end title 23
###begin p 24
###xml 33 34 33 34 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sup>
###xml 175 176 165 166 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 260 264 250 254 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008283-Braren1">[38]</xref>
###xml 857 861 843 847 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008283-Turner1">[39]</xref>
###xml 914 922 900 908 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 960 961 946 947 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sup>
72 hrs post viral infection, 3x105 EC were plated overnight with fresh media and subsequently incubated with 3 microg/ml BrDU (Sigma) for 2 hrs in 37degreesC incubator at 5%CO2. The cells were then fixed and BrDU staining was performed as previously described [38]. For all migration assays, EC obtained 72 hrs post viral infection were used. For Scratch Wound Assay, EC were cultured an additional 24 hrs until confluent, incubated with 15 ng/ml MitomycinC (Sigma) and wounded across the well surface with a 10-microl standard pipette tip. The wounded monolayers were then imaged over 24 hrs under the Live Imaging Zeiss microscope. Cell migration was calculated as the number of EC migrating into the wound area at various time points indicated. Single cell migration track assays were performed as previously described and quantified using Metamorph 6.0 [39]. The vessel-forming ability of EC was characterized in vitro using a Matrigel assay. Briefly, 4x104 EC were sandwiched between two layers of Matrigel (BD Biosciences, 10 mg/ml) and cultured in complete EC media. Tube formation was monitored over a period of a week.
###end p 24
###begin title 25
EC apoptosis and senescence assays
###end title 25
###begin p 26
###xml 335 339 335 339 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008283-Wei1">[35]</xref>
###xml 398 402 398 402 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008283-Dimri1">[40]</xref>
Serum starvation (0.1% serum for 24 hrs) was used to induce apoptosis in EC infected with lentivirus with and without Cre (72 hrs post infection). Apoptosis was assayed using fluorescence labeled LIVE/DEAD Cell Viability Kit (Invitrogen) according to the manufacturer's protocol and quantified using Metamorph6.0 as previous described [35]. Senescence assays were performed as previously described [40].
###end p 26
###begin title 27
Statistical Analysis
###end title 27
###begin p 28
General Linear Models were used to analyze staining differences in immunostaining experiments. MINITAB was used for the analyses.
###end p 28
###begin title 29
Results
###end title 29
###begin title 30
Ablation of Erk1 and Erk2 in EC results in embryonic lethality and defective angiogenesis
###end title 30
###begin p 31
###xml 53 59 53 59 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Erk1/2</italic>
###xml 132 140 132 140 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cre/LoxP</italic>
###xml 272 276 272 276 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Erk2</italic>
###xml 289 291 289 291 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fl</sup>
###xml 285 291 285 291 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Erk2<sup>fl</sup></italic>
###xml 316 320 316 320 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">loxP</italic>
###xml 328 332 328 332 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008283-Samuels1">[32]</xref>
###xml 385 389 385 389 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Erk1</italic>
###xml 389 393 389 393 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008283-Selcher1">[12]</xref>
###xml 433 441 433 441 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tie2-Cre</italic>
###xml 483 485 483 485 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fl</sup>
###xml 479 485 479 485 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Erk2<sup>fl</sup></italic>
###xml 492 496 492 496 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008283-Kisanuki1">[31]</xref>
###xml 521 524 521 524 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 529 534 529 534 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fl/fl</sup>
###xml 517 543 517 543 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Erk1<sup>&#8722;/&#8722;</sup>;Erk2<sup>fl/fl</sup>;Tie2-Cre</italic>
###xml 654 664 654 664 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0008283.s006">Figure S1A</xref>
###xml 858 862 858 862 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Erk1</italic>
###xml 866 870 866 870 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Erk2</italic>
###xml 919 927 919 927 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0008283.s001">Table S1</xref>
###xml 173 177 <span type="species:ncbi:10090">mice</span>
###xml 238 242 <span type="species:ncbi:10090">mice</span>
###xml 498 502 <span type="species:ncbi:10090">Mice</span>
###xml 552 556 <span type="species:ncbi:10090">mice</span>
###xml 714 718 <span type="species:ncbi:10090">mice</span>
In order to study the potential overlapping roles of Erk1/2 in the development of the vascular system, a genetic approach employing Cre/LoxP technology was used to generate mice with both genes absent in EC. For this purpose we generated mice homozygous for a conditional Erk2 allele, Erk2fl (with exon 2 flanked by loxP sites) [32], homozygous for the conventional knockout allele of Erk1[12], and containing the well-characterized Tie2-Cre transgene to effect recombination of Erk2fl in EC [31]. Mice with genotype Erk1-/-;Erk2fl/fl;Tie2-Cre (EC-DKO mice) were expected to be born at a frequency of 12.5% from the initial breeding scheme employed (see Figure S1A for breeding schemes). However, no mutant EC-DKO mice were born, suggesting embryonic lethality; other expected genotypes were found at the predicted ratios, indicating that one copy of either Erk1 or Erk2 in EC was sufficient for embryonic development (Table S1).
###end p 31
###begin p 32
###xml 151 159 151 159 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tie2-Cre</italic>
###xml 230 234 230 234 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008283-Kisanuki1">[31]</xref>
###xml 267 276 267 276 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008283-g001">Figure 1A</xref>
###xml 278 286 278 286 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0008283.s001">Table S1</xref>
###xml 291 293 291 293 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0008283.s002">S2</xref>
###xml 370 379 370 379 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008283-g001">Figure 1A</xref>
###xml 496 506 496 506 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0008283.s006">Figure S1B</xref>
###xml 631 639 631 639 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tie2-Cre</italic>
###xml 674 678 674 678 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008283-Kisanuki1">[31]</xref>
###xml 680 690 680 690 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0008283.s006">Figure S1D</xref>
###xml 896 906 896 906 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0008283.s006">Figure S1E</xref>
###xml 465 469 <span type="species:ncbi:10090">mice</span>
To determine when lethality occurred, embryos obtained from timed matings were studied, demonstrating that EC-DKO embryos were alive at E9.5, when the Tie2-Cre transgene utilized in these studies becomes active in the embryo body [31], but no longer viable at E10.5 (Figure 1A; Table S1 and S2). The viable EC-DKO E9.5 embryos were smaller than the control littermates (Figure 1A). There was no significant difference in the number of somites present in the mutant mice compared to the controls (Figure S1B). Blood vessels were not visible in the yolk sac of the EC-DKO embryos at E9.5, consistent with the timing of expression of Tie2-Cre in yolk sac beginning at E7.5-8.5 [31] (Figure S1D). Furthermore, EC-DKO mutant hearts were much smaller with highly reduced cellularity and the endocardial layer was detached from myocardial trabeculae suggesting defective heart development and function (Figure S1E).
###end p 32
###begin title 33
###xml 50 54 50 54 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Erk1</italic>
###xml 54 55 54 55 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 54 55 54 55 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>&#8722;</sup></italic>
###xml 55 56 55 56 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">/</italic>
###xml 56 57 56 57 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</italic>
###xml 55 57 55 57 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><italic>/</italic><italic>&#8722;</italic></sup>
###xml 62 67 62 67 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fl/fl</sup>
###xml 57 76 57 76 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">;Erk2<sup>fl/fl</sup>;Tie2-Cre</italic>
Embryonic Lethality and Defective Angiogenesis in Erk1-/-;Erk2fl/fl;Tie2-Cre mutant embryos.
###end title 33
###begin p 34
###xml 171 174 171 174 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 179 184 179 184 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fl/fl</sup>
###xml 167 193 167 193 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Erk1<sup>&#8722;/&#8722;</sup>;Erk2<sup>fl/fl</sup>;Tie2-Cre</italic>
(A) E10.5 day (top) and E9.5 (bottom) embryos; control embryo is at the left, DKO at the right. Bars = 0.5 mm. (B) Consecutive paraffin sections of control (left) and Erk1-/-;Erk2fl/fl;Tie2-Cre (EC-DKO) (right) embryos were stained with anti-ERK1/2 (top) and anti-CD31 (bottom) antibodies. Representative data for E9.5 embryo are shown; a total of 4 embryos were analyzed. Red dotted lines mark the outer lining of the EC layer and arrowheads point to representative EC. Bars = 20 microm. The graphic panel indicates the ratio of ERK positive EC to total CD31-positive cells, expressed as percent positive EC. (C) E9.5 embryos analyzed by whole mount staining with anti-CD31 antibody. Controls are in the top row and EC-DKO mutants in the bottom row. Arrowheads highlight examples of blood vessel staining and branching in the controls that are reduced in the EC-DKO embryos. Bars = 0.5 mm.
###end p 34
###begin p 35
###xml 29 35 29 35 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Erk1/2</italic>
###xml 332 341 332 341 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008283-g001">Figure 1B</xref>
###xml 510 520 510 520 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0008283.s006">Figure S1C</xref>
In order to verify that both Erk1/2 were selectively deleted in EC, immunohistochemistry was performed on sections from viable E9.5 embryos using a pan-ERK1/2 antibody. While robust ERK1/2 expression was detected in EC present in controls, a selective 8-fold reduction of ERK1/2 expression was observed in EC in the EC-DKO mutants (Figure 1B). Notably, there was no significant difference in ERK1/2 expression in other embryonic non-EC types such as smooth muscle cells, epithelial cells, cardiomyocytes etc. (Figure S1C).
###end p 35
###begin p 36
###xml 265 274 265 274 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008283-g001">Figure 1C</xref>
###xml 279 289 279 289 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0008283.s006">Figure S1F</xref>
###xml 735 745 735 745 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0008283.s006">Figure S1D</xref>
Whole mount CD31 staining was employed to determine the extent of angiogenic remodeling in the EC-DKO embryos, an analysis that revealed a striking reduction in vascular complexity in the EC-DKO embryos examined (n = 7) compared to controls (n = 10) at this stage (Figure 1C and Figure S1F). While the control littermates underwent extensive blood vessel branching and maturation at E9.5, the EC-DKO embryos had only large unbranched vessels, especially evident in the heart, head and trunk regions. Additionally, whole mount CD31 staining of EC-DKO yolk sacs (n = 4) revealed large vessels and decreased vascular density compared to the control littermates (n = 4), confirming that angiogenesis was impaired in this embryonic tissue (Figure S1D).
###end p 36
###begin title 37
Gene expression profiling of ERK1/2 deficient EC identified proliferation and migration as affected biological processes
###end title 37
###begin p 38
###xml 189 192 189 192 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 197 202 197 202 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fl/fl</sup>
###xml 185 202 185 202 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Erk1<sup>&#8722;/&#8722;</sup>;Erk2<sup>fl/fl</sup></italic>
###xml 361 379 361 379 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0008283.s007">Figure S2A and S2B</xref>
###xml 458 461 458 461 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cre</italic>
###xml 466 470 466 470 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">eGfp</italic>
###xml 501 505 501 505 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Erk1</italic>
###xml 510 514 510 514 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Erk2</italic>
###xml 554 557 554 557 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cre</italic>
###xml 705 714 705 714 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008283-g002">Figure 2A</xref>
###xml 719 729 719 729 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0008283.s007">Figure S2C</xref>
###xml 811 821 811 821 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0008283.s007">Figure S2D</xref>
###xml 859 862 859 862 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 867 872 867 872 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fl/fl</sup>
###xml 855 872 855 872 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Erk1<sup>&#8722;/&#8722;</sup>;Erk2<sup>fl/fl</sup></italic>
###xml 906 909 906 909 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cre</italic>
###xml 203 207 <span type="species:ncbi:10090">mice</span>
To directly address the mechanisms that might be contributing to the lethality in the double mutant embryos, primary aortic EC and microvascular lung EC were isolated and cultured from Erk1-/-;Erk2fl/fl mice. The EC identity and relative purity of the cultured cells was confirmed by the uptake of fluorescent-labeled low density lipoprotein and CD31 staining (Figure S2A and S2B). The purified cell populations were infected with lentivirus expressing both Cre and eGfp to generate aortic EC lacking Erk1 and Erk2 (DKO EC). The efficiency of lentiviral-Cre mediated recombination was analyzed by Western analysis and indirect immunofluorescence, demonstrating a 10-fold reduction in ERK2 protein levels (Figure 2A and Figure S2C, respectively). Similar results were obtained with the lung microvascular cells (Figure S2D). Aortic and lung EC of genotype Erk1-/-;Erk2fl/fl infected with lentivirus without Cre were used as controls for subsequent experiments.
###end p 38
###begin title 39
Loss of ERK1/2 in EC affects Cell cycle/proliferation and Cell migration/angiogenesis.
###end title 39
###begin p 40
###xml 107 110 107 110 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 115 120 115 120 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fl/fl</sup>
###xml 103 120 103 120 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Erk1<sup>+/&#8722;</sup>;Erk2<sup>fl/fl</sup></italic>
###xml 138 141 138 141 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 146 150 146 150 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">flfl</sup>
###xml 134 150 134 150 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Erk1<sup>&#8722;/&#8722;</sup>;Erk2<sup>flfl</sup></italic>
(A) Protein expression of ERK1/2 in lentivirus infected aortic control and DKO EC by Western analysis. Erk1+/-;Erk2fl/fl (lane 1) and Erk1-/-;Erk2flfl without (lane 2) and with (lane 3) Cre. (B) Principal biological processes affected by the loss of ERK1/2 in aortic EC. Indicated is the % genes differentially expressed in DKO EC. (C and D) Gene expression analysis of cell cycle/proliferation (C) and cell migration/ECM remodeling/angiogenesis (D) regulators by q-PCR in cultured aortic EC with and without ERK1/2, n = 3.
###end p 40
###begin p 41
###xml 481 489 481 489 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0008283.s004">Table S4</xref>
###xml 648 654 648 654 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Erk1/2</italic>
###xml 771 780 771 780 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008283-g002">Figure 2B</xref>
Subsequently, total RNA was isolated from DKO and control EC and subjected to gene expression profiling using the Affymetrix platform. The expression profiling was performed on three independent pairs of aortic EC cultures. RNA was isolated from DKO EC 72 hrs post lentiviral expression, sufficient time for endogenous ERK proteins to turn over. Analysis of the microarray data yielded 281 genes that showed 4-fold or greater, statistically significant changes in gene expression (Table S4). Of these, 144 genes were downregulated and 137 genes were upregulated. Gene ontology identified four principal biological processes affected by the loss of Erk1/2 in EC: cell cycle/proliferation, cell migration/angiogenesis, transcriptional regulation and inflammatory response (Figure 2B).
###end p 41
###begin p 42
###xml 532 540 532 540 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0008283.s005">Table S5</xref>
###xml 661 672 661 672 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008283-g002">Figure 2C-D</xref>
###xml 674 684 674 684 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0008283.s007">Figure S2E</xref>
###xml 706 710 706 710 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cd31</italic>
###xml 715 719 715 719 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Flt1</italic>
###xml 740 746 740 746 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Vegf-c</italic>
###xml 772 775 772 775 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p27</italic>
###xml 780 783 780 783 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p53</italic>
###xml 811 819 811 819 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Caspase3</italic>
###xml 868 878 868 878 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0008283.s007">Figure S2F</xref>
###xml 1068 1078 1068 1078 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0008283.s007">Figure S2G</xref>
To verify the microarray results, quantitative real-time RT-PCR (q-PCR) was performed on RNA prepared from an independently derived set of aortic EC. 35 genes with greater than four-fold differential expression that represented the major biological processes affected were selected for verification. In addition, we selected for q-PCR verification another 13 genes described in the literature to be regulated by ERK signaling (e.g. MMP9 and uPA), that were differentially expressed greater than two-fold in the microarray analysis (Table S5). All 48 genes tested by q-PCR were found to be significantly differentially expressed in DKO versus control aortic EC (Figure 2C-D; Figure S2E). EC-specific genes (Cd31 and Flt1), EC-growth factor (Vegf-c), cell cycle regulators (p27 and p53), and pro-apoptotic genes (Caspase3) were not significantly affected in the DKO EC (Figure S2F). Expression of many of the genes differentially regulated in DKO aortic EC was studied in the microvascular lung EC, revealing differential expression in this distinct type of EC as well (Figure S2G).
###end p 42
###begin title 43
###xml 40 47 40 47 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 52 60 52 60 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
Erk1 and Erk2 regulate EC proliferation in vivo and in vitro
###end title 43
###begin p 44
###xml 239 248 239 248 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008283-g003">Figure 3A</xref>
###xml 358 367 358 367 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008283-g003">Figure 3A</xref>
###xml 526 536 526 536 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0008283.s008">Figure S3A</xref>
###xml 863 872 863 872 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008283-g003">Figure 3B</xref>
Since the expression profiling results predicted differences in cell proliferation and migration, these processes were selected for further analysis. EC proliferation in EC-DKO embryos was analyzed by employing a BrDU incorporation assay (Figure 3A). EC-DKO mutant embryos showed a selective 3-fold decrease in BrDU incorporation in EC compared to controls (Figure 3A). Importantly, there was no significant difference in BrDU incorporation in other non-EC types such as smooth muscle cells, epithelial cells, cardiomyocytes (Figure S3A). Because previous studies had implicated ERK1/2 in EC survival during angiogenesis, cleaved Caspase-3 immunostaining was used to determine if EC apoptosis was affected in EC-DKO embryos. The results demonstrated that apoptosis was low in EC in E9.5 embryos, with no significant difference between EC-DKO and control embryos (Figure 3B).
###end p 44
###begin title 45
Reduced cell proliferation in ERK1/2 deficient EC.
###end title 45
###begin p 46
###xml 953 956 941 944 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 961 966 949 954 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fl/fl</sup>
###xml 949 966 937 954 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Erk1<sup>+/&#8722;</sup>;Erk2<sup>fl/fl</sup></italic>
###xml 985 988 973 976 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 993 998 981 986 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fl/fl</sup>
###xml 981 998 969 986 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Erk1<sup>&#8722;/&#8722;</sup>;Erk2<sup>fl/fl</sup></italic>
###xml 1020 1023 1008 1011 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1028 1033 1016 1021 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fl/fl</sup>
###xml 1016 1033 1004 1021 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Erk1<sup>&#8722;/&#8722;</sup>;Erk2<sup>fl/fl</sup></italic>
(A) Representative paraffin sections from E9.5 control (left, n = 4) and EC-DKO (right, n = 4) embryo sections stained for anti-BrDU. The red dotted lines indicate the outer lining of the EC layer and the arrowheads point to representative EC. The bar graph represents the fraction of BrDU positive to total EC. Bars = 20 microm. (B) Anti-cleaved Caspase-3 staining of representative paraffin sections from E9.5 control (left, n = 4) and EC-DKO (right, n = 4) embryo. The red dotted lines indicate the outer lining of the EC layer. The graphic panel indicates the fraction of EC staining for cleaved Caspase-3 to total EC. Bars = 20 microm. (C) Anti-BrDU staining on cultured aortic EC of the indicated genotype, without (top panel) and with (bottom panel) Cre. Red-BrDU and Blue-DaPI. The graph indicates the ratio of BrDU positive to total EC with 3 independent experiments represented. Bars = 20 microm. (D) Western blot analysis on lysates from Erk1+/-;Erk2fl/fl-Cre (lane 1), Erk1-/-;Erk2fl/fl-Cre (lane 2) and Erk1-/-;Erk2fl/fl+Cre for the antibodies indicated.
###end p 46
###begin p 47
###xml 20 27 20 27 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 124 132 124 132 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 134 143 134 143 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008283-g003">Figure 3C</xref>
###xml 253 263 241 251 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0008283.s008">Figure S3B</xref>
###xml 299 302 287 290 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Erk</italic>
###xml 393 403 381 391 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0008283.s008">Figure S3C</xref>
###xml 445 448 433 436 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Erk</italic>
###xml 536 543 524 531 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 658 668 646 656 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0008283.s008">Figure S3D</xref>
Consistent with the in vivo data, there was a 4.5-fold reduction in BrDU incorporation in DKO compared to control aortic EC in vitro (Figure 3C). DKO lung EC also showed approximately4-fold decrease in BrDU incorporation compared to wild-type controls (Figure S3B). Further, aortic EC with only one Erk allele do not show significant difference in BrDU incorporation compared to the controls (Figure S3C). This suggested that one copy of either Erk gene was sufficient to maintain normal EC proliferation. Additionally, consistent with in vivo results, there was no difference in apoptosis in DKO versus control aortic EC when stressed by serum deprivation (Figure S3D).
###end p 47
###begin p 48
###xml 248 257 248 257 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008283-g003">Figure 3D</xref>
###xml 378 387 378 387 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008283-g003">Figure 3D</xref>
Western blotting was used to analyze the expression of several cell cycle regulators in aortic EC. A marked diminution of proteins regulating G1 to S phase progression was observed, including CyclinD1, CyclinE, CDK4 and c-Myc in the DKO aortic EC (Figure 3D). Interestingly, the expression of G2-M regulators such as CyclinA, CyclinB1 and CDK1 were also lower in DKO aortic EC (Figure 3D).
###end p 48
###begin p 49
###xml 12 18 12 18 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Erk1/2</italic>
###xml 47 55 47 55 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 202 205 202 205 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Erk</italic>
###xml 291 301 288 298 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0008283.s008">Figure S3E</xref>
###xml 508 518 499 509 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0008283.s008">Figure S3E</xref>
Deletion of Erk1/2 in either aortic or lung EC in vitro led to marked morphological changes, including larger and flattened cells. To test whether cell senescence was being triggered by deletion of the Erk genes, we stained cells for SA-betagal activity, a biomarker of cellular senescence (Figure S3E). Neither DKO nor control aortic EC expressed SA-betagal under normal culture conditions; however, upon the induction of senescence by UV-irradiation, both DKO and control aortic EC stained for SA-betagal (Figure S3E). Thus, loss of ERK1/2 did not directly trigger cell senescence in cultured EC.
###end p 49
###begin title 50
###xml 0 6 0 6 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Erk1/2</italic>
###xml 73 81 73 81 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
Erk1/2 ablation in EC results in reduced EC migration and tube formation in vitro
###end title 50
###begin p 51
###xml 102 106 102 106 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Erk1</italic>
###xml 107 108 107 108 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</italic>
###xml 316 325 316 325 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008283-g004">Figure 4A</xref>
###xml 400 409 400 409 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008283-g004">Figure 4A</xref>
###xml 411 420 411 420 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0008283.s011">Movies S1</xref>
###xml 425 427 425 427 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0008283.s012">S2</xref>
###xml 483 493 483 493 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0008283.s009">Figure S4A</xref>
###xml 529 532 529 532 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Erk</italic>
###xml 604 614 604 614 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0008283.s009">Figure S4B</xref>
###xml 673 676 673 676 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Erk</italic>
###xml 920 930 920 930 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0008283.s009">Figure S4C</xref>
###xml 1263 1272 1263 1272 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008283-g004">Figure 4B</xref>
Three different assays that measure cell motility and invasiveness were used to examine the effect of Erk1/2 deletion on cell migration. Initially, a monolayer scratch wound assay was performed. After wounding (and in the presence of MitomycinC), control EC efficiently migrated into the wounded area within 24 hrs (Figure 4A). In contrast, the DKO aortic EC failed to migrate into the wounded area (Figure 4A, Movies S1 and S2). Similar results were also observed with DKO lung EC (Figure S4A). Further, aortic EC with only one Erk allele did not show significant differences in motility in this assay (Figure S4B). As above, this result suggested that one copy of either Erk gene was sufficient for normal EC migration. The results of the scratch assays from DKO and control EC were confirmed using a single cell migration track assay in which migrating cells engulf fluorescent beads leaving a non-fluorescent track (Figure S4C). A 6-fold decrease in motility of the DKO aortic EC compared to control was measured in this assay. Cell invasiveness of DKO EC was examined in a Matrigel "sandwich" assay with EC placed between two layers of Matrigel. The DKO aortic EC failed to invade into the Matrigel and to form tube-like structures as observed for controls (Figure 4B).
###end p 51
###begin title 52
###xml 67 75 67 75 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
EC lacking ERK1/2 display reduced migration and invasion potential in vitro.
###end title 52
###begin p 53
###xml 374 382 370 378 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">In vitro</italic>
(A) Confluent monolayer of control (top panel) and DKO (bottom panel) aortic EC were wounded and wound closure was monitored over 24 hrs. Representative results from t = 0 h (left panel) and t = 24 h (right panel) are shown (n = 3). The graph indicates the quantification of the number of cells migrating into the wound over the indicated time points. Bars = 40 microm. (B) In vitro matrigel sandwich assay showing invasion and tube-like formation by control aortic EC (top panel) that is absent in DKO EC (bottom panel). Left panel shows the phase contrast images and the right panel GFP images. Bars = 80 microm.
###end p 53
###begin title 54
Erk1/2 deletion altered expression and localization of Paxillin and FAK
###end title 54
###begin p 55
###xml 122 126 122 126 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008283-Klemke1">[19]</xref>
###xml 128 132 128 132 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008283-Webb1">[41]</xref>
###xml 134 138 134 138 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008283-Houle1">[42]</xref>
###xml 140 144 140 144 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008283-Rao1">[43]</xref>
###xml 446 455 446 455 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008283-g005">Figure 5A</xref>
###xml 460 470 460 470 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0008283.s010">Figure S5A</xref>
Previous studies in EC have shown that ERK1/2 regulate the organization of the actin cytoskeleton and hence cell motility [19], [41], [42], [43]. Consistent with these studies, phalloidin stained DKO compared to control aortic EC demonstrated a dramatic loss of actin cytoskeletal organization, in particular the loss of intracellular stress fibers and marked peripheral accumulation of actin in both aortic and lung DKO EC compared to controls (Figure 5A and Figure S5A).
###end p 55
###begin title 56
###xml 95 103 95 103 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
ERK1/2 deficient EC show altered actin organization and reduced expression of Paxillin and FAK in vitro.
###end title 56
###begin p 57
###xml 356 359 352 355 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 364 369 360 365 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fl/fl</sup>
###xml 352 369 348 365 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Erk1<sup>&#8722;/&#8722;</sup>;Erk2<sup>fl/fl</sup></italic>
###xml 384 387 380 383 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 392 397 388 393 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fl/fl</sup>
###xml 380 397 376 393 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Erk1<sup>&#8722;/&#8722;</sup>;Erk2<sup>fl/fl</sup></italic>
###xml 695 698 687 690 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 703 708 695 700 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fl/fl</sup>
###xml 691 708 683 700 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Erk1<sup>+/&#8722;</sup>;Erk2<sup>fl/fl</sup></italic>
###xml 726 729 718 721 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 734 739 726 731 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fl/fl</sup>
###xml 722 739 714 731 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Erk1<sup>&#8722;/&#8722;</sup>;Erk2<sup>fl/fl</sup></italic>
(A) Representative micrographs of phalloidin stained control (top) and DKO (bottom) aortic EC (n = 3). Red = Actin and Green = lentivirus infected cells. The bar graph represents % EC showing the presence of intra-cellular stress fibers. Bars = 20 microm. (B) Representative micrographs of Paxillin-pFAK membrane co-localization on FN-coated dishes in Erk1-/-;Erk2fl/fl (top) and Erk1-/-;Erk2fl/fl+Cre (bottom) aortic EC (n = 3). Red-Paxillin and Green-pY397 FAK. Boxed areas are enlarged to show membrane staining in EC. Graphic panel represents % EC showing Paxillin-pY397 FAK co-localization. Bars = 20 microm. (C) Western blot with indicated antibodies of lentivirus infected aortic EC. Erk1+/-;Erk2fl/fl (lane 1) and Erk1-/-;Erk2fl/fl without (lane 2) and with (lane 3) Cre.
###end p 57
###begin p 58
###xml 134 138 134 138 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008283-Mitra1">[44]</xref>
###xml 533 542 533 542 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008283-g005">Figure 5B</xref>
###xml 765 774 765 774 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008283-g005">Figure 5C</xref>
###xml 802 810 802 810 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Paxillin</italic>
###xml 815 818 815 818 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fak</italic>
###xml 957 967 957 967 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0008283.s010">Figure S5B</xref>
###xml 1037 1041 1037 1041 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008283-Shen1">[45]</xref>
###xml 1124 1134 1124 1134 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0008283.s010">Figure S5C</xref>
Paxillin and Focal Adhesion Kinase (FAK) are two factors indispensable for actin filament assembly, cell spreading and cell migration [44]. Indirect immunofluorescence was used to assess whether Paxillin and FAK localization were affected in DKO EC plated on fibronectin (FN) coated dishes. While the control EC demonstrated expression and co-localization of Paxillin and pY397-FAK at the membrane and within focal adhesions, staining was greatly diminished in DKO aortic EC and focal adhesions were not detected with these markers (Figure 5B). Consistent with the double immunofluorescence analysis, the expression of Paxillin and FAK (both total and pY397-FAK), were significantly reduced in DKO compared to control aortic EC as demonstrated by Western blotting (Figure 5C). The mRNA levels for both Paxillin and Fak, were unchanged in DKO EC compared to controls indicating that the changes in protein expression were due to post-transcriptional events (Figure S5B). The Paxillin/FAK complex activates the PI-3 Kinase pathway and AKT [45]. However, no difference in activated pS473-AKT was observed in the DKO aortic EC (Figure S5C).
###end p 58
###begin p 59
###xml 277 293 277 293 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008283-g006">Figure 6A and 6B</xref>
###xml 479 489 479 489 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0008283.s010">Figure S5D</xref>
To determine whether Paxillin and FAK were affected in EC-DKO embryos, immunohistochemistry was used to analyze their expression in E9.5 embryos. Importantly, EC-DKO embryos showed an 8-fold reduction in EC-specific staining for Paxillin and a 4-fold decrease in FAK staining (Figure 6A and 6B, respectively). There was no significant difference in Paxillin and FAK staining in the other embryonic non-EC types such as smooth muscle cells, epithelial cells, cardiomyocytes etc. (Figure S5D).
###end p 59
###begin title 60
###xml 64 71 64 71 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
ERK1/2 deficient EC show reduced expression of Paxillin and FAK in vivo.
###end title 60
###begin p 61
###xml 44 47 44 47 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 52 57 52 57 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fl/fl</sup>
###xml 40 57 40 57 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Erk1<sup>&#8722;/&#8722;</sup>;Erk2<sup>fl/fl</sup></italic>
###xml 81 84 81 84 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 89 94 89 94 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fl/fl</sup>
###xml 77 104 77 104 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Erk1<sup>&#8722;/&#8722;</sup>;Erk2<sup>fl/fl</sup> ;Tie2-Cre</italic>
###xml 332 335 332 335 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 340 345 340 345 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fl/fl</sup>
###xml 328 345 328 345 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Erk1<sup>&#8722;/&#8722;</sup>;Erk2<sup>fl/fl</sup></italic>
(A) Representative cryosections of E9.5 Erk1-/-;Erk2fl/fl control (left) and Erk1-/-;Erk2fl/fl ;Tie2-Cre (EC-DKO, right) embryos (n = 4 of each genotype) stained with anti-Paxillin. Graphic panel indicates the ratio of Paxillin positive area to total EC area in %. (B) Anti-FAK staining of representative cryosections from E9.5 Erk1-/-;Erk2fl/fl control (left, n = 4) and EC-DKO mutant (right, n = 4) embryo. Graphic panel indicates the ratio of FAK positive area to total EC area in %. Boxed areas are enlarged to show membrane staining in EC. The red dotted lines indicate the outer lining of the EC layer and the arrowheads point to representative EC. Lower magnification: Bars = 25 microm and Higher magnification: Bars = 20 microm.
###end p 61
###begin title 62
Discussion
###end title 62
###begin p 63
###xml 19 26 19 26 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 31 39 31 39 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 142 144 142 144 <monospace xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">. </monospace>
###xml 183 189 183 189 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Erk1/2</italic>
###xml 361 365 361 365 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Erk1</italic>
###xml 366 367 366 367 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</italic>
###xml 399 407 399 407 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 492 500 492 500 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 593 596 593 596 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008283-Cheresh1">[2]</xref>
###xml 598 602 598 602 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008283-Alavi1">[17]</xref>
###xml 604 608 604 608 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008283-Mavria1">[20]</xref>
The combination of in vivo and in vitro approaches presented here reveal an EC autonomous, redundant role for ERK1/2 in embryonic angiogenesis. The combined results demonstrated that Erk1/2 regulate both proliferation and migration of EC, two biological processes that are critical for angiogenesis. Surprisingly, cell apoptosis was not affected by ablation of Erk1/2 in EC as predicted by previous in vitro studies. A plausible explanation for this discrepancy might be that in the previous in vitro studies upstream components of the RAS/ERK pathway were targeted, in particular RAF and MEK [2], [17], [20]. Thus, the actual role of ERK1/2 in apoptosis was inferred but not directly tested in these studies. This raises the possibility that targets of RAF and MEK other than ERK1/2 may be involved in the observed affects of the pathway on EC survival.
###end p 63
###begin p 64
###xml 24 28 24 28 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Erk2</italic>
###xml 40 43 40 43 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 36 43 36 43 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Erk1<sup>&#8722;/&#8722;</sup></italic>
###xml 242 250 242 250 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tie2-Cre</italic>
###xml 272 276 272 276 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Erk2</italic>
###xml 375 379 375 379 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008283-Kisanuki1">[31]</xref>
EC-specific deletion of Erk2 in the Erk1-/- background resulted in embryonic lethality at E9.5-E10.5 and the viable EC-DKO E9.5 embryos were smaller than the control littermates. We speculate that the smaller size of EC-DKO embryos is due to Tie2-Cre mediated deletion of Erk2 starting at E7.5 in the yolk sac EC, and at E8.5 in the embryonic aorta and common atrial chamber [31]. In addition, reduced blood vessel development in the embryo proper likely contributes to the smaller size and in combination with defective heart development results in lethality of the EC-DKO mutant embryos.
###end p 64
###begin p 65
###xml 197 201 197 201 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008283-Schaller1">[46]</xref>
###xml 203 207 203 207 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008283-Schlaepfer1">[47]</xref>
###xml 786 790 786 790 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008283-Ishibe1">[48]</xref>
###xml 792 796 792 796 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008283-Liu2">[49]</xref>
One mechanism underlying ERK1/2 function in EC involves regulation of the expression of FAK and Paxillin. ERK1/2 have been most frequently placed downstream of Src-FAK signaling in several studies [46], [47], but our results demonstrate that ERK1/2 can also act upstream to regulate FAK and Paxillin expression. One hypothesis to account for this result is that ERK activation by tyrosine kinases is required for efficient expression of FAK and Paxillin, which in turn leads to amplification of ERK signaling when integrin/adhesion pathways are engaged. An alternate mechanism by which ERK can function upstream of these signaling proteins is that, as demonstrated in hepatocytes, ERK phosphorylation of Paxillin at Ser83 enhances formation of Paxillin/FAK complexes in focal adhesions [48], [49]. However, the drastic reduction in FAK and Paxillin expression in EC lacking ERK1/2 don't allow the potential role of this mechanism in EC to be tested. The precise mechanism by which ERK regulates FAK and Paxillin remains to be determined, but could involve selective regulation of translation of these proteins, including potentially through the regulation of specific microRNAs, or by affected turnover rates for these proteins.
###end p 65
###begin p 66
###xml 193 197 193 197 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008283-Shen1">[45]</xref>
###xml 199 203 199 203 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008283-Gilmore1">[50]</xref>
###xml 238 246 238 246 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tie2-Cre</italic>
###xml 280 283 280 283 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fak</italic>
###xml 466 470 466 470 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Erk1</italic>
###xml 482 486 482 486 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008283-Braren1">[38]</xref>
###xml 488 492 488 492 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008283-Shen2">[51]</xref>
FAK signaling has been linked to EC proliferation as well as migration, suggesting that the loss of FAK expression could account for the major phenotypes observed when ERK1/2 are ablated in EC [45], [50]. However, in two separate studies Tie2-Cre mediated conditional knockout of Fak resulted in a less severe phenotype than reported here, with embryonic lethality occurring at E11.5 or later, and without angiogenic phenotypes at E9.5 when defects are obvious with Erk1/2 deletion [38], [51]. In addition, EC apoptosis was identified as a major phenotype in both of these previous studies. Thus, other targets of ERK1/2 in addition to FAK and Paxillin likely account for the overall phenotype observed.
###end p 66
###begin p 67
###xml 305 309 <span type="species:ncbi:10090">mice</span>
The microarray analysis suggests that the nuclear function of ERK1/2 is also critical for their action in EC. For example, a number of genes involved in cell cycle regulation, in particular Cyclins, CDKs and c-Myc are among ERK targets that can account for cell proliferation defects in the double mutant mice. Similarly, the expression of several extracellular proteases (e.g., MMPs) involved in promoting cell motility and angiogenesis were downregulated while extracellular matrix components that inhibit angiogenesis (e.g., Thrombospondins 1 and 2) were increased by the absence of ERK1/2. Therefore, the ability of ERK1/2 to activate an assortment of transcription factors, either directly by phosphorylation or indirectly through activation of their expression, is key to their function in EC.
###end p 67
###begin p 68
###xml 18 26 18 26 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 31 38 31 38 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 80 84 80 84 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Erk1</italic>
###xml 89 93 89 93 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Erk2</italic>
In summary, these in vitro and in vivo results demonstrate a redundant role for Erk1 and Erk2 in EC, and indicate that targets at both the cell membrane and in the nucleus account for the ability of these kinases to regulate EC functions that are necessary for embryonic angiogenesis.
###end p 68
###begin title 69
Supporting Information
###end title 69
###begin p 70
###xml 27 30 27 30 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 36 41 36 41 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fl/fl</sup>
EMBRYONIC LETHALITY IN Erk1-/-; Erk2fl/fl; Tie2Cre DOUBLE MUTANT MICE
###end p 70
###begin p 71
(0.05 MB DOC)
###end p 71
###begin p 72
Click here for additional data file.
###end p 72
###begin p 73
###xml 27 30 27 30 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 36 41 36 41 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fl/fl</sup>
###xml 23 50 23 50 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Erk1<sup>&#8722;/&#8722;</sup>; Erk2<sup>fl/fl</sup>; Tie2Cre</italic>
EMBRYONIC LETHALITY IN Erk1-/-; Erk2fl/fl; Tie2Cre DOUBLE MUTANT MICE
###end p 73
###begin p 74
(0.04 MB DOC)
###end p 74
###begin p 75
Click here for additional data file.
###end p 75
###begin p 76
MICROARRAY EXPERIMENTAL DESIGN
###end p 76
###begin p 77
(0.05 MB DOC)
###end p 77
###begin p 78
Click here for additional data file.
###end p 78
###begin p 79
LIST OF GENES DIFFERENTIALLY EXPRESSED (4 FOLD OR GREATER) IN DKO EC BY MICROARRAY ANALYSIS
###end p 79
###begin p 80
(0.32 MB DOC)
###end p 80
###begin p 81
Click here for additional data file.
###end p 81
###begin p 82
LIST OF GENES DIFFERENTIALLY EXPRESSED IN DKO AORTIC AND LUNG EC BY CONFIRMED BY qPCR ANALYSIS
###end p 82
###begin p 83
(0.07 MB DOC)
###end p 83
###begin p 84
Click here for additional data file.
###end p 84
###begin p 85
###xml 68 71 68 71 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 76 81 76 81 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fl/fl</sup>
###xml 64 90 64 90 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Erk1<sup>&#8722;/&#8722;</sup>;Erk2<sup>fl/fl</sup>;Tie2-Cre</italic>
###xml 603 606 603 606 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 611 616 611 616 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fl/fl</sup>
###xml 599 625 599 625 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Erk1<sup>&#8722;/&#8722;</sup>;Erk2<sup>fl/fl</sup>;Tie2-Cre</italic>
(A) Schematic illustration of the breeding strategies to obtain Erk1-/-;Erk2fl/fl;Tie2-Cre mutant embryos. Solid triangles represent the loxP sites. (B) Bar graph indicating the number of somites in E9.5 embryos with 3 (grey), 2(white), 1(hatched) and 0 (black) copies of Erk. (C) Graphic panel indicates the ratio of ERK positive to total non-EC, expressed as percent positive non-EC types such as smooth muscle cells, epithelial cells, cardiomyocytes etc. (D) Freshly dissected yolk sac from E9.5 embryos (top) and micrographs of anti-CD31 stained yolk sacs (bottom) from control (left panel) and Erk1-/-;Erk2fl/fl;Tie2-Cre (EC-DKO) mutant (right panel) embryos. Top panel: Bars = 0.25 mm and Bottom panel: Bars = 50microm. (E) Representative paraffin sections from E9.5 control (left, n = 3) and EC-DKO (right, n = 3) embryo sections stained with nuclear fast red. The arrowheads indicate the cellularity of heart. Bars = 20 microm. (F) Head regions from E9.5 embryos analyzed by whole mount staining with anti-CD31 antibody. Controls are in the top row and EC-DKO mutants in the bottom row. Arrowheads highlight examples of blood vessel staining and branching in the controls that are reduced in the EC-DKO embryos.
###end p 85
###begin p 86
(3.45 MB TIF)
###end p 86
###begin p 87
Click here for additional data file.
###end p 87
###begin p 88
###xml 65 68 65 68 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 73 78 73 78 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fl/fl</sup>
###xml 61 78 61 78 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Erk1<sup>&#8722;/&#8722;</sup>;Erk2<sup>fl/fl</sup></italic>
###xml 689 692 681 684 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 697 702 689 694 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fl/fl</sup>
###xml 685 702 677 694 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Erk1<sup>+/&#8722;</sup>;Erk2<sup>fl/fl</sup></italic>
###xml 721 724 713 716 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 729 734 721 726 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fl/fl</sup>
###xml 717 734 709 726 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Erk1<sup>&#8722;/&#8722;</sup>;Erk2<sup>fl/fl</sup></italic>
###xml 756 759 748 751 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 764 769 756 761 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fl/fl</sup>
###xml 752 769 744 761 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Erk1<sup>&#8722;/&#8722;</sup>;Erk2<sup>fl/fl</sup></italic>
###xml 79 83 <span type="species:ncbi:10090">mice</span>
(A) Typical high speed FACS analysis for cells isolated from Erk1-/-;Erk2fl/fl mice using PE-labeled Di-I-Ac-LDL. Pink curve (M1) shows FACS for the PE-negative population. Purple curve (M2) shows FACS for the PE-positive EC population. The blue curve shows the M2 population that was sorted and collected, and then reanalyzed by FACS. (B) PECAM (green) and DAPI (blue) staining of aortic EC. The third figure in the panel is the merged imaged as indicated. Bars = 20 microm. (C) Anti-ERK1/2 staining on cultured aortic EC of the indicated genotype, without (top panel) and with (bottom panel) Cre. Red-ERK1/2 and Blue-DaPI. Bars = 20 microm. (D) Western blot analysis on lysates from Erk1+/-;Erk2fl/fl-Cre (lane 1), Erk1-/-;Erk2fl/fl-Cre (lane 2) and Erk1-/-;Erk2fl/fl+Cre lung EC for ERK1/2. (E) Gene expression analysis of transcription regulators by q-PCR in aortic EC with and without ERK1/2. (F) Putative target gene expression analysis aortic EC with and without ERK1/2. Note that the expression of these genes was not affected by Erk1/2 status. (G) Gene expression analysis of cell cycle/proliferation, transcription and cell migration/ECM remodeling/angiogenesis regulators downregulated (left panel) and upregulated (right panel) by qPCR in cultured lung EC with and without ERK1/2. ND-not detected.
###end p 88
###begin p 89
(25.27 MB TIF)
###end p 89
###begin p 90
Click here for additional data file.
###end p 90
###begin p 91
(A) Graphic panel indicating the ratio of BrDU positive to total non-EC types such as smooth muscle cells, epithelial cells, cardiomyocytes etc., expressed as percent positive non-EC. (B) Anti-BrDU staining on cultured lung EC of the indicated genotype, without (top panel) and with (bottom panel) Cre. Red-BrDU and Blue-DaPI. Bars = 20 microm. The graph shows the quantification of the staining data represented as % BrDU positive EC. (C) Anti-BrDU staining on cultured aortic EC of the indicated genotype, without (top panel, 3 Erk copies) and with (bottom panel,1 Erk copy) Cre. Red-BrDU and Blue-DaPI. Bars = 20 microm. The graph shows the quantification of the staining data represented as % BrDU positive EC. (D) Live/Dead staining of control (top panels) and DKO (bottom panels) aortic EC. GFP-lentivirus infected cells and Red-EthD1/apoptotic cells. Graph at right is quantification of the results. Bars = 40 microm. (E) Senescence associated beta-gal staining on control (top) and mutant (bottom) aortic EC before (left panels) and after (right panels) UV induction. Bars = 100 microm. The bar graph indicates the quantification of the results represented as % beta-gal positive EC.
###end p 91
###begin p 92
(4.52 MB TIF)
###end p 92
###begin p 93
Click here for additional data file.
###end p 93
###begin p 94
(A) Confluent monolayer of control (top panel) and DKO (bottom panel) lung EC were wounded and wound closure was monitored over 24 hrs. Representative results from t = 0 h (left panel) and t = 24 h (right panel) are shown. Graph on the right illustrates the quantification of the number of cells migrating into the wound over the indicated time points. Bars = 40 microm. (B) Confluent monolayer of aortic EC of the indicated genotype, without (top panel, 3 Erk copies) and with (bottom panel,1 Erk copy) Cre were wounded and wound closure was monitored over 24 hrs. Representative results from t = 0 h (left panel) and t = 24 h (right panel) are shown. Graph on the right illustrates the quantification of the number of cells migrating into the wound over the indicated time points. Bars = 40 microm. (C) Migration track assay on control (left) and a mixed population of DKO (right) aortic EC. The GFP expressing cells in the right panel are the mutant EC lacking both Erk1/2 and the non-GFP cells are the uninfected population of control EC. Graphic panel indicates the quantification of the non-fluorescent tracks represented as average area migrated per cell in %.
###end p 94
###begin p 95
(1.93 MB TIF)
###end p 95
###begin p 96
Click here for additional data file.
###end p 96
###begin p 97
###xml 213 221 209 217 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Paxillin</italic>
###xml 226 229 222 225 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fak</italic>
###xml 325 328 321 324 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 333 338 329 334 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fl/fl</sup>
###xml 321 338 317 334 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Erk1<sup>+/&#8722;</sup>;Erk2<sup>fl/fl</sup></italic>
###xml 357 360 353 356 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 365 370 361 366 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fl/fl</sup>
###xml 353 370 349 366 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Erk1<sup>&#8722;/&#8722;</sup>;Erk2<sup>fl/fl</sup></italic>
###xml 392 395 388 391 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 400 405 396 401 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fl/fl</sup>
###xml 388 405 384 401 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Erk1<sup>&#8722;/&#8722;</sup>;Erk2<sup>fl/fl</sup></italic>
(A) Immunofluorescence micrographs of actin staining in control (top) and DKO (bottom) lung EC by phalloidin staining. Red-Actin and Green-lentivirus infected EC. Bars = 20 microm. (B) Gene expression analysis of Paxillin and Fak by q-PCR in aortic EC of the indicated genotype. (C) Western blot analysis on lysates from Erk1+/-;Erk2fl/fl-Cre (lane 1), Erk1-/-;Erk2fl/fl-Cre (lane 2) and Erk1-/-;Erk2fl/fl+Cre lung EC for pS473-AKT. (D) Graphic panels indicate the ratio of Paxillin (left) and FAK (right) positive to total non-EC (such as smooth muscle cells, epithelial cells, cardiomyocytes etc) area respectively in %.
###end p 97
###begin p 98
(1.39 MB TIF)
###end p 98
###begin p 99
Click here for additional data file.
###end p 99
###begin p 100
Wound Healing Assay on Erk1/2 Wild type endothelial cells.
###end p 100
###begin p 101
(14.07 MB AVI)
###end p 101
###begin p 102
Click here for additional data file.
###end p 102
###begin p 103
Wound Healing Assay on Erk1/2 DKO endothelial cells.
###end p 103
###begin p 104
(13.69 MB AVI)
###end p 104
###begin p 105
Click here for additional data file.
###end p 105
###begin p 106
###xml 241 249 <span type="species:ncbi:9606">Children</span>
We acknowledge the Ohio State University Comprehensive Cancer Center's Real-time PCR, Flow Cytometry, Microarray, Genomics and Microscopy & Imaging Shared Resources for their roles in supporting this work. We also acknowledge the Cincinnati Children's Hospital Medical Center Viral Vector Core. We thank Martina Gutik and Histology Core Facility for excellent technical assistance and Dr. Sudarshana Sharma for intellectual input. We thank the University Laboratory Animal staff for providing excellent animal care.
###end p 106
###begin title 107
References
###end title 107
###begin article-title 108
Molecular regulation of vessel maturation.
###end article-title 108
###begin article-title 109
Regulation of angiogenesis: apoptotic cues from the ECM.
###end article-title 109
###begin article-title 110
Integrin alphavbeta3 requirement for sustained mitogen-activated protein kinase activity during angiogenesis.
###end article-title 110
###begin article-title 111
Differential alphav integrin-mediated Ras-ERK signaling during two pathways of angiogenesis.
###end article-title 111
###begin article-title 112
The role of phosphatidylinositol 3-kinase and the mitogen-activated protein kinases in insulin-like growth factor-I-mediated effects in vascular endothelial cells.
###end article-title 112
###begin article-title 113
Lack of ERK activation and cell migration in FGF-2-deficient endothelial cells.
###end article-title 113
###begin article-title 114
H-ras regulates angiogenesis and vascular permeability by activation of distinct downstream effectors.
###end article-title 114
###begin article-title 115
Essential role of B-Raf in ERK activation during extraembryonic development.
###end article-title 115
###begin article-title 116
###xml 34 38 <span type="species:ncbi:10090">mice</span>
Embryonic death of Mek1-deficient mice reveals a role for this kinase in angiogenesis in the labyrinthine region of the placenta.
###end article-title 116
###begin article-title 117
###xml 50 54 <span type="species:ncbi:10090">mice</span>
Vascular system defects and neuronal apoptosis in mice lacking ras GTPase-activating protein.
###end article-title 117
###begin article-title 118
###xml 40 44 <span type="species:ncbi:10090">mice</span>
Endothelial apoptosis in Braf-deficient mice.
###end article-title 118
###begin article-title 119
###xml 0 4 <span type="species:ncbi:10090">Mice</span>
Mice lacking the ERK1 isoform of MAP kinase are unimpaired in emotional learning.
###end article-title 119
###begin article-title 120
###xml 39 43 <span type="species:ncbi:10090">mice</span>
Study of MAPK signaling using knockout mice.
###end article-title 120
###begin article-title 121
Extracellular signal-regulated kinase 2 is necessary for mesoderm differentiation.
###end article-title 121
###begin article-title 122
Essential role for ERK2 mitogen-activated protein kinase in placental development.
###end article-title 122
###begin article-title 123
###xml 70 75 <span type="species:ncbi:10090">mouse</span>
An essential function of the mitogen-activated protein kinase Erk2 in mouse trophoblast development.
###end article-title 123
###begin article-title 124
Role of Raf in vascular protection from distinct apoptotic stimuli.
###end article-title 124
###begin article-title 125
Tumor regression by targeted gene delivery to the neovasculature.
###end article-title 125
###begin article-title 126
Regulation of cell motility by mitogen-activated protein kinase.
###end article-title 126
###begin article-title 127
ERK-MAPK signaling opposes Rho-kinase to promote endothelial cell survival and sprouting during angiogenesis.
###end article-title 127
###begin article-title 128
Inhibition of tumor endothelial ERK activation, angiogenesis, and tumor growth by sorafenib (BAY43-9006).
###end article-title 128
###begin article-title 129
Decursin and decursinol inhibit VEGF-induced angiogenesis by blocking the activation of extracellular signal-regulated kinase and c-Jun N-terminal kinase.
###end article-title 129
###begin article-title 130
###xml 72 77 <span type="species:ncbi:9606">human</span>
Vascular endothelial growth factor regulates focal adhesion assembly in human brain microvascular endothelial cells through activation of the focal adhesion kinase and related adhesion focal tyrosine kinase.
###end article-title 130
###begin article-title 131
###xml 27 32 <span type="species:ncbi:9606">human</span>
VEGF prevents apoptosis of human microvascular endothelial cells via opposing effects on MAPK/ERK and SAPK/JNK signaling.
###end article-title 131
###begin article-title 132
Nitric oxide is an upstream signal of vascular endothelial growth factor-induced extracellular signal-regulated kinase1/2 activation in postcapillary endothelium.
###end article-title 132
###begin article-title 133
Extracellular signal-regulated protein kinase/Jun kinase cross-talk underlies vascular endothelial cell growth factor-induced endothelial cell proliferation.
###end article-title 133
###begin article-title 134
Integrating the VEGF signals leading to actin-based motility in vascular endothelial cells.
###end article-title 134
###begin article-title 135
###xml 116 121 <span type="species:ncbi:9606">human</span>
p38 MAP kinase activation by vascular endothelial growth factor mediates actin reorganization and cell migration in human endothelial cells.
###end article-title 135
###begin article-title 136
Src kinase phosphorylates vascular endothelial-cadherin in response to vascular endothelial growth factor: identification of tyrosine 685 as the unique target site.
###end article-title 136
###begin article-title 137
###xml 96 101 <span type="species:ncbi:9606">human</span>
MAP kinases, phosphatidylinositol 3-kinase, and p70 S6 kinase mediate the mitogenic response of human endothelial cells to vascular endothelial growth factor.
###end article-title 137
###begin article-title 138
###xml 9 24 <span type="species:ncbi:10090">transgenic mice</span>
Tie2-Cre transgenic mice: a new model for endothelial cell-lineage analysis in vivo.
###end article-title 138
###begin article-title 139
Deletion of ERK2 mitogen-activated protein kinase identifies its key roles in cortical neurogenesis and cognitive function.
###end article-title 139
###begin article-title 140
###xml 63 69 <span type="species:ncbi:10090">murine</span>
An efficient, nonenzymatic method for isolation and culture of murine aortic endothelial cells and their response to inflammatory stimuli.
###end article-title 140
###begin article-title 141
###xml 114 120 <span type="species:ncbi:10090">murine</span>
Base excision repair proteins are required for integrin-mediated suppression of bleomycin-induced DNA breakage in murine lung endothelial cells.
###end article-title 141
###begin article-title 142
Ets1 and Ets2 are required for endothelial cell survival during embryonic angiogenesis.
###end article-title 142
###begin article-title 143
Exploration, normalization, and summaries of high density oligonucleotide array probe level data.
###end article-title 143
###begin article-title 144
Requisite role of angiopoietin-1, a ligand for the TIE2 receptor, during embryonic angiogenesis.
###end article-title 144
###begin article-title 145
Endothelial FAK is essential for vascular network stability, cell survival, and lamellipodial formation.
###end article-title 145
###begin article-title 146
Prostate-derived ETS factor is a mediator of metastatic potential through the inhibition of migration and invasion in breast cancer.
###end article-title 146
###begin article-title 147
Regulation of a senescence checkpoint response by the E2F1 transcription factor and p14(ARF) tumor suppressor.
###end article-title 147
###begin article-title 148
FAK-Src signalling through paxillin, ERK and MLCK regulates adhesion disassembly.
###end article-title 148
###begin article-title 149
DAP kinase mediates the phosphorylation of tropomyosin-1 downstream of the ERK pathway, which regulates the formation of stress fibers in response to oxidative stress.
###end article-title 149
###begin article-title 150
Prostaglandin E2-EP4 receptor promotes endothelial cell migration via ERK activation and angiogenesis in vivo.
###end article-title 150
###begin article-title 151
Focal adhesion kinase: in command and control of cell motility.
###end article-title 151
###begin article-title 152
Differential regulation of cell migration and cell cycle progression by FAK complexes with Src, PI3K, Grb7 and Grb2 in focal contacts.
###end article-title 152
###begin article-title 153
Complex formation with focal adhesion kinase: A mechanism to regulate activity and subcellular localization of Src kinases.
###end article-title 153
###begin article-title 154
Multiple Grb2-mediated integrin-stimulated signaling pathways to ERK2/mitogen-activated protein kinase: summation of both c-Src- and focal adhesion kinase-initiated tyrosine phosphorylation events.
###end article-title 154
###begin article-title 155
Paxillin serves as an ERK-regulated scaffold for coordinating FAK and Rac activation in epithelial morphogenesis.
###end article-title 155
###begin article-title 156
Hepatocyte growth factor induces ERK-dependent paxillin phosphorylation and regulates paxillin-focal adhesion kinase association.
###end article-title 156
###begin article-title 157
Inhibition of focal adhesion kinase (FAK) signaling in focal adhesions decreases cell motility and proliferation.
###end article-title 157
###begin article-title 158
Conditional knockout of focal adhesion kinase in endothelial cells reveals its role in angiogenesis and vascular development in late embryogenesis.
###end article-title 158
###begin p 159
###xml 0 21 0 21 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Competing Interests: </bold>
Competing Interests: The authors have declared that no competing interests exist.
###end p 159
###begin p 160
###xml 0 9 0 9 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Funding: </bold>
Funding: NCI grants R01-CA53271, P01-CA097189 and the Evelyn Simmers Foundation (MCO). TZ was funded by a predoctoral fellowship from the Department of Defense Breast Cancer Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
###end p 160

